Skip to content

Clinical trials

Terminated Muscular Dystrophies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophies Status: Terminated Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20122
20131
20141
20151
20161
20171
20181
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical2
Fulcrum Therapeutics2
Catabasis Pharmaceuticals1
Cedars-Sinai Medical Center1
Cooperative International Neuromuscular Research Group1
Hoffmann-La Roche1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
Kyntra Bio1
Mallinckrodt ARD LLC1
National Heart, Lung, and Blood Institute (NHLBI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophies15
Muscular Dystrophy, Duchenne10
Neuromuscular Diseases6
Musculoskeletal Diseases5
Muscular Diseases3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Disorders, Atrophic2
Muscular Dystrophy, Facioscapulohumeral2
Nervous System Diseases2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.